ImmunityBio Shares Face Unrelenting Downward Spiral

The biotechnology sector is demonstrating its notoriously unforgiving nature, with ImmunityBio caught in a severe downturn. As the company’s stock continues to face intense selling activity, investors are questioning whether the bottom has been reached or if further declines are imminent.

Technical analysis presents a concerning outlook for ImmunityBio. Both short-term and long-term moving averages are generating clear sell signals. Since a reversal point in mid-September, the equity has already surrendered more than 20 percent of its value, with technical indicators suggesting additional losses until a new support level is established.

The current technical picture shows four negative signals against zero positive ones—a decisive message. Resistance levels at Read more...